Treatment of childhood acute lymphoblastic leukemia in Iraq: a 17-year experience from a single center

References

• Pui CH, Yang JJ, Bhakta N, et al. Global efforts toward the cure of childhood acute lymphoblastic leukemia. Lancet Child Adolesc Health. 2018;2(6):440–454.
   PubMedGoogle Scholar
• Pui CH, Evans WE. A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol. 2013;50(3):185–196.
   PubMed Web of Science ®Google Scholar
• Pui CH. Precision medicine in acute lymphoblastic leukemia. Front Med. 2020;14(6):689–700.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Galindo C, Friedrich P, Morrissey L, et al. Global challenges in pediatric oncology. Curr Opin Pediatr. 2013;25(1):3–15.
   PubMed Web of Science ®Google Scholar
• Valery PC, Moore SP, Meiklejohn J, et al. International variations in childhood cancer in indigenous populations: a systematic review. Lancet Oncol. 2014;15(2):e90–e103.
   PubMed Web of Science ®Google Scholar
• Steliarova-Foucher E, Colombet M, Ries LAG, et al. International incidence of childhood cancer, 2001–2010: a population-based registry study. Lancet Oncol. 2017;18(6):719–731.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram II, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Galindo C, Friedrich P, Alcasabas P, et al. Toward the cure of all children with cancer through collaborative efforts: pediatric oncology as a global challenge. J Clin Oncol. 2015;33(27):3065–3073.
   PubMed Web of Science ®Google Scholar
• Heck JE, Park AS, Contreras ZA, et al. Risk of childhood cancer by maternal birthplace: a test of the Hispanic paradox. JAMA Pediatr. 2016;170(6):585–592.
   PubMed Web of Science ®Google Scholar
• Katz AJ, Chia VM, Schoonen WM, et al. Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden. Cancer Causes Control. 2015;26(11):1627–1642.
   PubMed Web of Science ®Google Scholar
• Howard SC, Davidson A, Luna-Fineman S, et al. A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries. The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP). Pediatr Blood Cancer. 2017;64:e26879.
   Web of Science ®Google Scholar
• Pacheco C, Lucchini G, Valsecchi MG, et al. Childhood acute lymphoblastic leukemia in Nicaragua: long-term results in the context of an international cooperative program. Pediatr Blood Cancer. 2014;61(5):827–832.
   PubMed Web of Science ®Google Scholar
• Ribeiro RC, Antillon F, Pedrosa F, et al. Global pediatric oncology: lessons from partnerships between high-income countries and low- to mid-income countries. J Clin Oncol. 2016;34(1):53–62.
   PubMed Web of Science ®Google Scholar
• Jaime-Perez JC, Jimenez-Castillo RA, Pinzon-Uresti M, et al. Real-world outcomes of treatment for acute lymphoblastic leukemia during adolescence in a financially restricted environment: results at a single center in Latin America. Pediatr Blood Cancer. 2017;64(7):1–8.
   Web of Science ®Google Scholar
• Abdelmabood S, Fouda AE, Boujettif F, et al. Treatment outcomes of children with acute lymphoblastic leukemia in a middle-income developing country: high mortalities, early relapses, and poor survival. J Pediatr. 2020;96(1):108–116.
   Web of Science ®Google Scholar
• Al-Hadad S, Al-Jadiry MF. Future planning to upgrade the pediatric oncology service in the Baghdad Children Welfare Teaching Hospital. J Pediatr Hematol Oncol. 2012;34(Suppl. 1):S19–S20.
   PubMed Web of Science ®Google Scholar
• Mitchell CD, Richards SM, Kinsey SE, et al. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. Br J Haematol. 2005;129(6):734–745.
   PubMed Web of Science ®Google Scholar
• Eiser C, Stride CB, Vora A, et al. Prospective evaluation of quality of life in children treated with UKALL 3003 for acute lymphoblastic leukemia: a cohort study. Pediatr Blood Cancer. 2017;64(11):e26615.
   Web of Science ®Google Scholar
• Jackson RK, Liebich M, Berry P, et al. Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukemia – a report from the UKALL 2011 trial. Eur J Cancer. 2019;120:75–85.
   PubMed Web of Science ®Google Scholar
• Moricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy for acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2009;113(18):4478.
   Web of Science ®Google Scholar
• Al-Kzayer LFY, Sakashita K, Matsuda K, et al. Genetic evaluation of childhood acute lymphoblastic leukemia in Iraq using FTA cards. Pediatr Blood Cancer. 2012;59(3):461–467.
   PubMed Web of Science ®Google Scholar
• Al-Kzayer LFY, Sakashita K, Al-Jadiry MF, et al. Analysis of KRAS and NRAS gene mutations in Arab Asian children with acute leukemia: high frequency of RAS mutations in acute lymphoblastic leukemia. Pediatr Blood Cancer. 2015;62(12):2157–2161.
   PubMed Web of Science ®Google Scholar
• Navarrete M, Rossi E, Brivio E, et al. Treatment of childhood acute lymphoblastic leukemia in Central America: a lower-middle income countries experience. Pediatr Blood Cancer. 2014;61(5):803–809.
   PubMed Web of Science ®Google Scholar
• Jabeen K, Ashraf MS, Iftikhar S, et al. The impact of socioeconomic factors on the outcome of childhood acute lymphoblastic leukemia (ALL) treatment in a low/middle income country (LMIC). J Pediatr Hematol Oncol. 2016;38(8):587–596.
   PubMed Web of Science ®Google Scholar
• Fung A, Horton S, Zabih V, et al. Cost and cost-effectiveness of childhood cancer treatment in low-income and middle-income countries: a systematic review. BMJ Glob Health. 2019;4(5):e001825.
   PubMed Web of Science ®Google Scholar
• Gupta S, Antillon FA, Bonilla M, et al. Treatment-related mortality in children with acute lymphoblastic leukemia in Central America. Cancer. 2011;117(20):4788–4795.
   PubMed Web of Science ®Google Scholar
• Gao YJ, Lu FJ, Wang HS. Treating childhood acute lymphoblastic leukemia in a developing country 1998–2003: the experience of a single children’s hospital. J Pediatr Hematol Oncol. 2006;28(12):798–802.
   PubMed Web of Science ®Google Scholar
• Antillón FG, Blanco JG, Valverde PD, et al. The treatment of childhood acute lymphoblastic leukemia in Guatemala: biologic features, treatment hurdles, and results. Cancer. 2017;123(3):436–448.
   PubMed Web of Science ®Google Scholar
• Yeoh AEJ, Tan D, Li C-K, et al. Management of adult and paediatric acute lymphoblastic leukemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet Oncol. 2013;14(12):e508–e523.
   PubMed Web of Science ®Google Scholar
• Koc A, Aycicek A, Ozdemir ZC, et al. Outcome of modified St Jude total therapy 13A for childhood acute lymphoblastic leukemia in the southeast region of Turkey. J Pediatr Hematol Oncol. 2013;35(1):36–41.
   PubMedGoogle Scholar
• Abboud MR, Ghanem K, Muwakkit S. Acute lymphoblastic leukemia in low and middle-income countries: disease characteristics and treatment results. Curr Opin Oncol. 2014;26(6):650–655.
   PubMed Web of Science ®Google Scholar
• Trehan A, Bansal D, Varma N, et al. Improving outcome of acute lymphoblastic leukemia with a simplified protocol: report from a tertiary care center in North India. Pediatr Blood Cancer. 2017;64(4):e26281.
   Web of Science ®Google Scholar
• Kersten E, Scanlan P, DuBois SG, et al. Current treatment and outcome for childhood acute leukemia in Tanzania. Pediatr Blood Cancer. 2013;60(12):2047–2053.
   PubMed Web of Science ®Google Scholar
• Jaime-Perez JC, Lopez-Razo ON, Garcia-Arellano G, et al. Results of treating childhood acute lymphoblastic leukemia in a low-middle income country: 10 year experience in northeast Mexico. Arch Med Res. 2016;47:668–676.
   PubMed Web of Science ®Google Scholar
• Pedrosa F, Shaikh F, Rivera G, et al. The impact of prospective telemedicine implementation in the management of childhood acute lymphoblastic leukemia in Recife, Brazil. Telemed J E Health. 2017;23(10):863–869.
   PubMed Web of Science ®Google Scholar
• Yeh TC, Liu HC, Hou JY, et al. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis. Cancer. 2014;120(8):1255–1262.
   PubMed Web of Science ®Google Scholar
• Jimenez-Hernandez E, Jaimes EZ, Arellano-Galindo J, et al. Survival of Mexican children with acute lymphoblastic leukemia under treatment with the protocol from the Dana-Farber institute 00-01. Biomed Res Int. 2015;2015:1–9.
   Web of Science ®Google Scholar
• Mushtaq N, Fadoo Z, Naqvi A. Childhood acute lymphoblastic leukaemia: experience from a single tertiary care facility of Pakistan. J Pak Med Assoc. 2013;63:1399–1404.
   PubMed Web of Science ®Google Scholar
• Jaime-Perez JC, Jimenez-Castillo RA, Pinzon-Uresti MA, et al. Real-world outcomes of treatment for acute lymphoblastic leukemia during adolescence in a financially restricted environment: results at a single center in Latin America. Pediatr Blood Cancer. 2017;64.
   Google Scholar
• Muwakkit S, Al-Aridi C, Samra A, et al. Implementation of an intensive risk-stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon. Am J Hematol. 2012;87(7):678–683.
   PubMed Web of Science ®Google Scholar
• Jastaniah W. Improving survival outcomes of childhood acute lymphoblastic leukemia: a 25-year experience from a single center in Saudi Arabia. Pediatr Blood Cancer. 2019;66(11):e27782.
   PubMed Web of Science ®Google Scholar
• Henze G, Stackelberg AV, Eckert C. ALL-REZ-BFM – the consecutive trials for children with relapsed acute lymphoblastic leukemia. Klin Padiatr. 2013;225(S01):S73–S78.
   PubMed Web of Science ®Google Scholar